News

Cathy Tie slips on a white lab coat bearing her name and the logo of her startup: Origin Genomics. "Welcome!" she says as she leads an NPR reporter, photographer and videographer on an exclusive tour of Origin's labs located...

This is the 17th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. The series is organized by Osagie K. Obasogie in...

THE INSTAGRAM POST, precision-guided by sex and age, had zeroed in on its target. Yuchen Tu is a conser­vatory-trained viola...

This is the 16th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring...

By Mike Celizic, The TODAY Show | 03.03.2009

Imagine ordering a baby like dinner: “We’ll take the boy in the Greek-god model, but can you make him 6-foot-4...

By United Press International, United Press International [cites Marcy Darnovsky] | 03.02.2009

The birth of octuplets in California calls attention to a lack of regulation in the field of assisted reproduction, some...

By BBC, BBC News | 03.02.2009

The LA Fertility Institutes run by Dr Jeff Steinberg, a pioneer of IVF in the 1970s, expects a trait-selected baby...

By Suzanne Bohan, Bay Area News Group | 03.01.2009
The Los Angeles doctor who performed in vitro fertilization on a 33-year-old woman who gave birth to octuplets in January...
By Philip Sherwell, The Telegraph | 02.28.2009
The Fertility Institutes clinic has just started offering prospective parents the opportunity to select physical traits of future offspring thanks...
By Michelle Nichols and Angela Moore , Reuters | 02.27.2009
Drawn by payments of up to $10,000, an increasing number of women are offering to sell their eggs at U.S...
By Jennifer Bails, Philadelphia Inquirer | 02.25.2009
Don't get Chrissy Glen wrong.

After four years spent coping with the heartache of infertility treatments that didn't work, she...
By Rob Stein, Washington Post | 02.24.2009
A handful of biotech companies are racing to market a new generation of tests for Down syndrome, a development that...